The ASHP Midyear Clinical Meetings and Exhibition is hosted by the American Society of Health System Pharmacists. The meeting focuses on professional development, networking, updating practice skills for pharmacy professionals, and staying current with the latest products and innovations in pharmacy.
Case Study: Remote Work Increases Productivity for Medication History Technicians
December 6th 2021The case study details the methodology employed by a large academic medical center to convert its medication history technician program’s workflow from on-site with in-person patient interviews to completely remote services.
Ambulatory Care Pharmacists in Diabetes Education Centers Can Help Improve Diabetes Outcomes
January 5th 2021The objective of the study was to evaluate the impact of the ambulatory care pharmacist intervention on A1C changes in patients with uncontrolled type 2 diabetes mellitus (T2DM) during a 2-year period at the diabetes education center.
Managing Therapies in Patients With Cervical and Endometrial Cancers
January 5th 2021Pharmacists play a key role in educating patients on risk factors for cervical and endometrial cancers and can assist with treatment decisions, and management of potential adverse effects in patients with these cancers.
Understanding the 340B Prime Vendor Program and Supporting Stakeholders During COVID-19
December 15th 2020Under the 340B Prime Vendor Program, the Prime Vendor has several functions that it carries out to support stakeholders in operating and navigate the field so that they can effectively achieve lower 340B drug pricing for those who need it most.
Utilizing Education and Machine Learning to Establish an Opioid Prescription Stewardship Program
December 14th 2020Monitoring outpatient prescribing patterns has been a major challenge for the Lifespan health system in Rhode Island, since it has over 1.5 million electronic prescriptions written annually.
The Cardiorenal Benefits, Risks of Treating Type 2 Diabetes With SGLT2 Inhibitors
December 11th 2020There are compelling reasons to use sodium-glucose cotransporter-2 (SGLT2) inhibitors for the treatment of type 2 diabetes, according to a session at the 2020 ASHP Midyear Clinical Meeting and Exhibition.
Unfounded Preventions, Treatments for COVID-19 and the Pharmacist Role in Educating the Public
December 11th 2020The objective of the study was to increase awareness among pharmacists about products for which unfounded claims have been made regarding prevention of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infections.